This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

• Guggenheim analyst Seamus Fernandez initiated coverage on Cidara Therapeutics, Inc. (NASDAQ:CDTX) with a Buy rating and announced a price target of $33. Cidara Therapeutics shares closed at $13.11 on Thursday. See how other analysts view this stock.
• RBC Capital analyst Leonid Timashev initiated coverage on Cytokinetics, Incorporated (NASDAQ:CYTK) with an Outperform rating and announced a price target of $80. Cytokinetics shares closed at $55.84 on Thursday. See how other ...

Full story available on Benzinga.com